| IL12A-AS1 |
|
IL12A antisense RNA 1
|
|
|
0.633 |
0.654 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| IGF2-AS |
Q6U949
|
IGF2 antisense RNA
|
|
|
0.612 |
0.615 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| IFNG-AS1 |
|
IFNG antisense RNA 1
|
|
|
0.659 |
0.654 |
| LINC01250 |
|
long intergenic non-protein coding RNA 1250
|
|
|
0.743 |
0.231 |
| LINC00993 |
|
long intergenic non-protein coding RNA 993
|
|
|
0.729 |
0.269 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
| AP4B1-AS1 |
|
AP4B1 antisense RNA 1
|
|
|
0.805 |
0.231 |
| LINC01185 |
|
long intergenic non-protein coding RNA 1185
|
|
|
0.743 |
0.346 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
| STX17-AS1 |
|
STX17 antisense RNA 1
|
|
|
0.890 |
0.192 |
| TPI1P2 |
|
triosephosphate isomerase 1 pseudogene 2
|
|
|
0.839 |
0.115 |
| LINC01088 |
|
long intergenic non-protein coding RNA 1088
|
|
|
0.821 |
0.308 |
| FAM86B3P |
|
family with sequence similarity 86, member A pseudogene
|
|
|
0.931 |
0.115 |
| TRIM26BP |
|
tripartite motif containing 26B, pseudogene
|
|
|
0.861 |
0.269 |
| HNRNPA1P1 |
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 1
|
|
|
0.931 |
0.154 |
| WAKMAR2 |
|
wound and keratinocyte migration associated lncRNA 2
|
|
|
0.931 |
0.115 |